Stockscreener 앱 받기
11.46
0.95%
-0.11
시간 외 거래:
11.46
전일 마감가:
$11.57
열려 있는:
$11.68
하루 거래량:
1.09M
Relative Volume:
1.60
시가총액:
$528.27M
수익:
$524.73M
순이익/손실:
$31.70M
주가수익비율:
17.32
EPS:
0.6617
순현금흐름:
$22.47M
1주 성능:
+4.95%
1개월 성능:
-15.74%
6개월 성능:
-32.39%
1년 성능:
-11.16%
1일 변동 폭
$11.43
$11.84
1주일 범위
$10.57
$12.27
52주 변동 폭
$9.72
$20.36
Core Laboratories Inc Stock (CLB) Company Profile
Compare CLB vs SLB, BKR, HAL, TS, FTI
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLB
Core Laboratories Inc
|
11.46 | 537.03M | 524.73M | 31.70M | 22.47M | 0.6617 |
SLB
Slb Ltd
|
45.13 | 69.51B | 35.91B | 3.38B | 4.41B | 2.2806 |
BKR
Baker Hughes Company
|
52.78 | 55.06B | 27.89B | 3.15B | 2.29B | 3.1363 |
HAL
Halliburton Co
|
32.96 | 28.36B | 22.17B | 1.55B | 1.68B | 1.8227 |
TS
Tenaris Sa Adr
|
54.13 | 28.01B | 12.19B | 2.03B | 1.87B | 3.8072 |
FTI
Technipfmc Plc
|
66.75 | 26.43B | 10.17B | 1.08B | 1.34B | 2.6138 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-12 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-06-30 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2023-04-18 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-01-09 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-10-07 | 업그레이드 | Citigroup | Sell → Neutral |
| 2022-09-26 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-04-18 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
| 2021-10-18 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-07-09 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-14 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2020-12-18 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-11-11 | 재확인 | Cowen | Market Perform |
| 2020-10-13 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2020-09-29 | 업그레이드 | ABN Amro | Sell → Hold |
| 2020-07-16 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2020-04-13 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2020-03-09 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2020-03-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-01-31 | 재확인 | Cowen | Market Perform |
| 2020-01-30 | 재개 | Johnson Rice | Buy |
| 2020-01-14 | 개시 | Bernstein | Mkt Perform |
| 2020-01-02 | 다운그레이드 | Stifel | Buy → Hold |
| 2019-12-31 | 재확인 | Cowen | Market Perform |
| 2019-07-10 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-02-25 | 업그레이드 | Tudor Pickering | Hold → Buy |
| 2018-12-19 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2018-12-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-11-16 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2018-11-01 | 업그레이드 | ABN Amro | Sell → Buy |
| 2018-10-29 | 재확인 | Cowen | Market Perform |
모두보기
Core Laboratories Inc 주식(CLB)의 최신 뉴스
Core Laboratories Inc.(NYSE: CLB) dropped from S&P 600 Energy - marketscreener.com
Core Laboratories Inc.(NYSE:CLB) dropped from S&P 600 Oil & Gas Equipment & Services (Sub Ind) - marketscreener.com
Core Laboratories Inc.(NYSE: CLB) dropped from S&P 600 - marketscreener.com
CORE LABORATORIES ANNOUNCES TIMING OF SECOND QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL - Morningstar
Price to earnings forward of Core Laboratories Inc. – NYSE:CLB - TradingView
Core Laboratories Inc.(NYSE: CLB) added to Russell 2000 Value-Defensive Index - marketscreener.com
Core Laboratories Inc.(NYSE: CLB) added to Russell 2000 Defensive Index - marketscreener.com
Core Laboratories Inc. Actuals & Estimates (NYSE:CLB) - TradingView
Core Laboratories Inc. Actuals & Estimates (FWB:HJ1) - TradingView
S&P SmallCap 600 swaps in Gulfport Energy and Mobility Global - Stock Titan
CLB Forecast — Price Target — Prediction for 2027 - TradingView
HJ1 Forecast — Price Target — Prediction for 2027 - TradingView
Core Laboratories Inc (CLB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Core Laboratories Inc. Actuals & Estimates (LS:A3EB9S) - TradingView
Core Laboratories Inc (CLB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Core Laboratories Inc (CLB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Core Laboratories (CLB) Faces Severe Decline with F Momentum Gra - GuruFocus
Core Laboratories Inc (CLB) Institutional Confidence - TradingKey
Core Laboratories Inc (CLB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Core Laboratories Inc (CLB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Core Laboratories Inc (CLB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Core Laboratories Inc (CLB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Core Laboratories Inc (CLB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Why Core Lab’s Proteus DTS quietly changes how wells are monitored - AD HOC NEWS
Core Laboratories StockWeekly move and sector check at the end of a soft week - AD HOC NEWS
CLB Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Is Core Laboratories Inc (CLB) a Bargain After 4.2% Drop? GF Val - GuruFocus
Noble Corporation, Valaris, and Core Laboratories Shares Plummet, What You Need To Know - TradingView
Select Water Solutions and Core Laboratories Shares Plummet, What You Need To Know - TradingView
CLB Q1 2026 Earnings: EPS Misses Estimates, Stock WeakensProfit Announcement - newsline.com
CLB News | CORE LABORATORIES INC (NYSE:CLB) - ChartMill
Core Laboratories and Helmerich & Payne Shares Are Soaring, What You Need To Know - TradingView
Core Lab Stock Plunges 18% in 3 Months: Time to Hold or Fold? - Zacks Investment Research
TETRA Technologies and Core Laboratories Shares Skyrocket, What You Need To Know - TradingView
Core Laboratories Inc stock (NL0015000CZ2): Oilfield services specialist navigates mixed demand afte - AD HOC NEWS
World Time-of-Flight Mass SpectrometersMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Core Laboratories Inc stock (NL0015000CZ2): shares trade around mid-teens ahead of recent Q1 update - AD HOC NEWS
Winners And Losers Of Q1: Core Laboratories (NYSE:CLB) Vs The Rest Of The Oilfield Services Stocks - Yahoo Finance
Distek Launches BIOne Core Software for Cloud-Based Bioprocess Data Management - Lab Manager
Core Laboratories (CLB) Among Most Expensive Energy Stocks Under $2B - GuruFocus
Core Laboratories Inc. (CLB) Edges Higher: Modest Gain Amid Sector Recovery PotentialInstitutional Volume - The Legal Advocate
Core Laboratories Inc stock (NL0015000CZ2): steady trading on NYSE ahead of next earnings update - AD HOC NEWS
CLB Q1 2026 Earnings: EPS Misses Estimates by 45.16% Amid Operational HeadwindsROIC Trend Report - The Legal Advocate
Core Laboratories (CLB) Down 4.9% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Core Laboratories (CLB) Slips 0.19% as Shares Nears Key Support LevelMerger Arbitrage - The Legal Advocate
CLBCore Laboratories Inc Stock Price and Quote - Finviz
Core Laboratories Q1 2026 Earnings: EPS Falls 45% Short of Estimates, Stock DeclinesLow Estimate Range - The Legal Advocate
1 Profitable Stock with Impressive Fundamentals and 2 Facing Challenges - Yahoo Finance
Core in Action: Turning Measured Data into Intelligent Insight with RAPID™ - marketscreener.com
Core Laboratories (CLB) Rallies 2% as Energy Sector Shows Renewed MomentumRip Sell Trade - Město Břeclav
Implied volatility surging for Core Laboratories stock options - MSN
Core Laboratories Inc (CLB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Core Laboratories Inc 주식 (CLB) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Murray Katherine | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
8,069 |
0 |
29,290 |
| ANASTASIO CURT | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
8,069 |
0 |
23,805 |
| Klingensmith Harvey Robert | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
8,069 |
0 |
50,031 |
| Temeng Kwaku | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
8,069 |
0 |
33,597 |
| MARTINOVICH ROBERT F | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
8,069 |
0 |
8,069 |
| Carnes Martha Z. | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
8,069 |
0 |
54,397 |
| Tattoli Mark Damian | SVP, Gen Counsel & Secretary |
Dec 31 '25 |
Option Exercise |
0.00 |
24,952 |
0 |
41,671 |
| Gresham Gwendolyn | SVP |
Dec 31 '25 |
Option Exercise |
0.00 |
24,952 |
0 |
52,527 |
| Hill Christopher Scott | SVP & CFO |
Dec 31 '25 |
Option Exercise |
0.00 |
61,417 |
0 |
142,354 |
| Bruno Lawrence | Chairman and CEO |
Dec 31 '25 |
Option Exercise |
0.00 |
180,722 |
0 |
370,119 |
8.49%
3.49%
자본화:
|
볼륨(24시간):